Qi Cao

6PUBLICATIONS
6CO-AUTHORS
Cellular immunologyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 21, 2026
Unveiling the Metabolic Milieu of Tertiary Lymphoid Expansion.

Qi Cao

|May 07, 2025
Targeting inflammation with chimeric antigen receptor macrophages using a signal switch.

Qi Cao, Yiping Wang, Jianwei Chen

|Apr 07, 2022
Interleukin-33 Exacerbates IgA Glomerulonephritis in Transgenic Mice Overexpressing B Cell Activating Factor.

Yuan Min Wang, Karli Shaw, Geoff Yu Zhang

|Oct 09, 2020
IL-10 producing type 2 innate lymphoid cells prolong islet allograft survival.

Qingsong Huang, Xiaoqian Ma, Yiping Wang

|Jan 04, 2018
Potentiating Tissue-Resident Type 2 Innate Lymphoid Cells by IL-33 to Prevent Renal Ischemia-Reperfusion Injury.

Qi Cao, Yiping Wang, Zhiguo Niu

|Nov 29, 2017
Redirecting TGF-<i>β</i> Signaling through the <i>β</i>-Catenin/Foxo Complex Prevents Kidney Fibrosis.

Xi Qiao, Padmashree Rao, Yun Zhang

Pageof 1